cordycepin has been researched along with Lung Injury, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Q; Lei, J; Li, Y; Song, P; Wei, Y; Xu, G; Zhang, T | 1 |
| Huang, Z; Qing, R; Tang, Y; Xiang, Q; Yang, F | 1 |
2 other study(ies) available for cordycepin and Lung Injury, Acute
| Article | Year |
|---|---|
Cordycepin inhibits LPS-induced acute lung injury by inhibiting inflammation and oxidative stress.
Topics: Acute Lung Injury; Animals; Deoxyadenosines; Gene Expression Regulation, Enzymologic; Heme Oxygenase-1; Inflammation; Interleukin-1beta; Lipopolysaccharides; Male; Malondialdehyde; Membrane Proteins; Mice; Mice, Inbred BALB C; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Tumor Necrosis Factor-alpha | 2018 |
Cordycepin alleviates lipopolysaccharide-induced acute lung injury via Nrf2/HO-1 pathway.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Cell Count; Cytokines; Deoxyadenosines; Heme Oxygenase (Decyclizing); Lipopolysaccharides; Lung; Male; NF-E2-Related Factor 2; Nitric Oxide Synthase Type II; Rats, Wistar; Signal Transduction; Toll-Like Receptor 4; Up-Regulation | 2018 |